Patient must undergo preoperative urine culture to rule out active urinary tract infection (UTI), which is an absolute contraindication. Prophylactic intravenous antibiotics are administered within 60 minutes prior to the first incision. The patient must observe NPO (nil per os) status for at least 8 hours for solids and 2 hours for clear liquids. Preoperative hair removal at the surgical site is performed using electric clippers. Blood pressure and coagulation status must be optimized, and all blood-thinning medications should be discontinued as per clinical guidelines.
Post-operative care requires monitoring of the surgical site for hematoma or signs of infection. A urinary catheter is usually placed for 24 hours. The device remains in the 'deactivated' state post-operatively to prevent cuff erosion while the tissues heal. Patients are advised to avoid heavy lifting or vigorous activity for 6 weeks. Activation of the device occurs at the 6-week post-operative follow-up clinic visit. Discharge is permitted once the patient is voiding adequately and pain is controlled with oral analgesics.
Comprehensive Clinical Guide: Artificial Urinary Sphincter (AUS) Implantation
The Artificial Urinary Sphincter (AUS) remains the gold-standard surgical intervention for the management of moderate-to-severe male stress urinary incontinence (SUI), particularly cases secondary to prostatectomy, pelvic trauma, or congenital anomalies. This guide provides a high-level clinical overview for medical professionals and patients seeking an authoritative understanding of the AUS implantation procedure.
1. Introduction and Clinical Overview
Artificial Urinary Sphincter (AUS) implantation is a prosthetic surgical procedure designed to restore urinary continence in patients who have failed conservative management. The device functions as a hydraulic, fluid-filled system that mimics the natural sphincter mechanism, providing active compression of the urethra to prevent involuntary urine leakage.
The Mechanism of Action
The AUS system is a closed-loop hydraulic circuit consisting of three primary components:
1. The Urethral Cuff: Placed around the bulbar urethra, this component inflates to occlude the urethral lumen.
2. The Pressure-Regulating Balloon (PRB): Usually placed in the pre-peritoneal space, this reservoir maintains the fluid pressure within the system, ensuring consistent coaptation of the cuff.
3. The Control Pump: Implanted within the scrotum, this allows the patient to manually deflate the cuff, diverting fluid into the balloon to allow for micturition.
2. Technical Specifications and Components
Understanding the mechanical integrity of the AUS is critical for surgical planning. The most widely utilized device is the AMS 800™ (Boston Scientific).
| Component | Function | Location |
|---|---|---|
| Urethral Cuff | Provides circumferential occlusion | Bulbar urethra |
| Balloon Reservoir | Regulates system pressure | Space of Retzius (Pre-peritoneal) |
| Control Pump | Allows patient-controlled voiding | Scrotum |
Material Science
The device is constructed from medical-grade silicone elastomer. Modern iterations often feature an antibiotic-impregnated coating (InhibiZone™) to minimize the risk of post-operative infection, which remains the most catastrophic complication for prosthetic implants.
3. Clinical Indications and Patient Selection
The AUS is indicated for patients with intrinsic sphincter deficiency (ISD) resulting in stress urinary incontinence.
Primary Indications
- Post-Prostatectomy Incontinence (PPI): The most common indication. Patients must be at least 6–12 months post-surgery to ensure the stabilization of urinary function.
- Post-Radiation Incontinence: While radiation increases the risk of tissue atrophy and erosion, the AUS remains a viable, albeit higher-risk, option.
- Neuropathic Bladder: In specific, well-selected cases where bladder compliance is preserved.
- Traumatic Urethral Injury: Following pelvic fracture or urethral reconstruction.
Critical Pre-Operative Requirements
Before surgery, a thorough evaluation is mandatory:
* Cystoscopy: To rule out urethral strictures, bladder stones, or bladder neck contractures.
* Urodynamic Studies: To evaluate bladder capacity and compliance. An overactive bladder (OAB) must be managed medically before AUS implantation, as the device cannot fix urge incontinence.
* Urinalysis/Culture: Must be sterile. Any UTI must be treated aggressively prior to scheduling.
* Physical Dexterity: The patient must have sufficient manual dexterity to operate the scrotal pump.
4. The Surgical Procedure: A Step-by-Step Breakdown
The procedure is typically performed under general or spinal anesthesia.
Step 1: Incision and Exposure
A perineal incision is the standard approach for placing the cuff around the bulbar urethra. Alternatively, a penoscrotal approach may be utilized depending on surgeon preference and anatomy.
Step 2: Urethral Dissection
The bulbar urethra is carefully dissected from the surrounding corpus spongiosum. Precise measurement of the urethral circumference is vital to select the correct cuff size (typically ranging from 4.0 cm to 5.0 cm).
Step 3: Balloon Placement
A second incision (usually a small inguinal or lower abdominal incision) is made to create a space in the pre-peritoneal area. The pressure-regulating balloon is inserted and filled with a contrast/saline solution.
Step 4: Pump Implantation
The control pump is placed in a sub-dartos pouch within the scrotum. The surgeon must ensure the pump is easily palpable and accessible for the patient.
Step 5: Tubing and Deactivation
The components are connected using kink-resistant tubing. The device is "deactivated" at the time of surgery, meaning the cuff remains deflated to allow for post-operative tissue healing without pressure necrosis.
5. Post-Operative Recovery and Protocol
Immediate Recovery (0–6 weeks)
- Infection Control: Prophylactic antibiotics are continued post-operatively.
- Activity Restriction: No heavy lifting (>10 lbs) or strenuous activity for 6 weeks to prevent device displacement.
- Pain Management: Typically managed with oral analgesics.
Activation Protocol (6–8 weeks)
The device is activated in the outpatient clinic. The surgeon ensures the patient can successfully cycle the pump. Patients are educated on the "pump-wait-pump" mechanism to ensure the bladder is fully emptied.
6. Risks, Complications, and Contraindications
Potential Complications
| Complication | Risk Factor | Management |
|---|---|---|
| Infection | Diabetes, previous radiation | Explantation (mandatory) |
| Erosion | Radiation, tight cuff | Explantation/Replacement |
| Urethral Atrophy | Long-term compression | Cuff downsizing or tandem cuff |
| Mechanical Failure | Wear and tear (10+ years) | Revision/Component replacement |
Contraindications
- Uncontrolled UTI: Absolute contraindication until resolved.
- Severe Bladder Instability: The AUS will not resolve urge-based leakage.
- Poor Cognitive Function: Patient must understand the mechanics of the device.
7. Alternative Treatments
Patients who are not candidates for an AUS may consider:
1. Male Sling: Indicated for mild-to-moderate SUI. Less invasive but generally less effective than the AUS for severe cases.
2. Bulking Agents: Injections into the bladder neck. Generally have lower long-term success rates.
3. Conservative Management: Pelvic floor physical therapy and lifestyle modifications (indicated for mild cases).
8. Frequently Asked Questions (FAQ)
1. How long does an Artificial Urinary Sphincter last?
Most devices last between 7 to 10 years. Mechanical failure or tissue changes may necessitate revision sooner.
2. Is the surgery painful?
Post-operative pain is generally well-controlled with standard analgesics. Most patients report mild scrotal discomfort for 1–2 weeks.
3. Does the AUS prevent urge incontinence?
No. The AUS is designed for stress incontinence. Urge symptoms must be managed with medications like anticholinergics or beta-3 agonists.
4. Can I still have sex after the surgery?
Yes. Patients are generally cleared for sexual activity once the incision is fully healed, typically 6–8 weeks post-surgery.
5. What happens if I get a urinary tract infection?
A UTI is a serious concern with any implant. You must contact your urologist immediately for aggressive antibiotic therapy.
6. Will I need to empty my bladder differently?
Yes. You will learn to use the scrotal pump to deflate the cuff, allowing urine to flow. After voiding, the cuff will slowly re-inflate on its own.
7. Does radiation therapy affect the outcome?
Radiation damages the tissue, making the urethra more prone to erosion. While the AUS can still be used, the risk of complication is statistically higher.
8. What is the success rate?
Success is defined as the use of one or no pads per day. In experienced centers, success rates typically exceed 85–90%.
9. Can the device be deactivated?
Yes. The device can be deactivated by a urologist in the office if necessary, such as during a temporary medical issue or to facilitate certain diagnostic procedures.
10. Does insurance cover this procedure?
In the United States and many other countries, the AUS is considered a standard-of-care medical necessity and is typically covered by insurance, provided clinical documentation supports the diagnosis of SUI.
9. Conclusion
The Artificial Urinary Sphincter is a transformative intervention that restores dignity and quality of life for men suffering from severe stress urinary incontinence. While the procedure carries inherent surgical risks, particularly regarding infection and mechanical longevity, its track record of success makes it the definitive treatment for long-term continence. Patients should consult with a fellowship-trained reconstructive urologist to determine their suitability for this life-changing technology.
Disclaimer: This document is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition or surgical procedure.
